Related Experiment Video
Updated: Jan 29, 2026

Measuring Glutathione-induced Feeding Response in Hydra
Published on: November 16, 2014
Glutathione peroxidase 4 as an emerging therapeutic target in osteoarthritis: focus on ferroptosis
Lin Zhang1, Jinglin Li1, Xuxu Yang1
1Department of Orthopedics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Abstract:
Osteoarthritis (OA) is a degenerative joint disease characterized by articular cartilage degradation, extracellular matrix breakdown, low-grade chronic inflammation, and pain. Its etiology is complex and treatment options are limited. In recent years, ferroptosis, a regulated form of cell death driven by iron-dependent lipid peroxidation, has gained significant attention in OA pathogenesis. Glutathione peroxidase 4(GPX4), serves as the central enzyme that halts lipid peroxidation and inhibits ferroptosis. Its expression and activity are altered in OA cartilage under pathological conditions, suggesting a crucial role for GPX4 in OA pathogenesis and treatment. This review summarizes the molecular characteristics and antioxidant functions of GPX4, evaluates experimental evidence linking GPX4 and ferroptosis in OA, outlines upstream and downstream molecular mechanisms regulating GPX4, and summarizes therapeutic strategies targeting GPX4, including pharmacological, gene, and combination therapies. It also discusses current research challenges and future directions. Finally, key pathways and strategic recommendations for translating GPX4 and ferroptosis research into clinical OA treatments are proposed.
Insights
Glutathione peroxidase 4 (GPX4) plays a key role in osteoarthritis by regulating ferroptosis, a cell death process. Targeting GPX4 offers promising new therapeutic strategies for treating osteoarthritis.
Area of Science:
- Biomedical Science
- Molecular Biology
- Pathology
Background:
- Osteoarthritis (OA) is a degenerative joint disease with limited treatment options.
- Ferroptosis, an iron-dependent cell death, is increasingly recognized in OA pathogenesis.
- Glutathione peroxidase 4 (GPX4) is a critical inhibitor of ferroptosis, with altered expression in OA.
Purpose of the Study:
- To review the role of GPX4 in osteoarthritis pathogenesis.
- To explore therapeutic strategies targeting GPX4 for OA treatment.
- To discuss challenges and future directions for clinical translation.
Main Methods:
- Literature review of experimental evidence linking GPX4 and ferroptosis in OA.
- Analysis of molecular mechanisms regulating GPX4.
- Summary of current and potential therapeutic interventions.
Main Results:
- GPX4's expression and activity are altered in OA cartilage.
- GPX4 inhibition promotes ferroptosis, contributing to OA.
- Targeting GPX4 presents potential therapeutic avenues for OA.
Conclusions:
- GPX4 is a crucial mediator in OA pathogenesis via ferroptosis.
- Therapeutic strategies targeting GPX4 show promise for OA treatment.
- Further research is needed to translate GPX4-based therapies into clinical practice.
Related Concept Videos
Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing
This therapeutic technique can also be used when a patient brings up pertinent information during a health-related conversation. The...
Emerging Adulthood
Introduction Cardiac Emergencies
Therapeutic Index
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Focusing of Light in the Eye

